Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
Clinical trial NCT00107913 · UNKNOWN
Trial details
- NCT number
- NCT00107913
- Sponsor
- Hematology and Oncology Specialists
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.